Effects of 3-dimensional Versus Dynamic Myofascial Release Techniques With Lumbar Mobilization and Exercise Therapy Program in Chronic Non-specific Low Back Pain.

November 2, 2026 updated by: Riphah International University

Effects of 3-Dimensional Versus Dynamic Myofascial Release Techniques With Lumbar Mobilization and Exercise Therapy Program in Chronic Non-Specific Low Back Pain.

Ninety percent of cases of LBP are nonspecific, which means they do not have an obvious reason like an infection or tumor. Pain that spreads from the thoracic spine to the gluteal area and upper leg is a common sign. Pain that lasts 12 weeks or more is classified as chronic. Non-specific low back pain (NSLBP) is marked by limits in facet joints, increased myofascial thickness, and lower lumbar flexibility, which can lead to further dysfunction. 3D-MFR works on fascia in three planes (sagittal, frontal, and transverse) to remove multidirectional limitations, mostly guided by the therapist. In contrast, DMFR is an active method that combines fascial release and joint mobilization, requiring the therapist to perform movements while the patient continually breathes in a synchronized pattern throughout therapy. While the therapeutic effects of MFR have been extensively studied, but dynamic technique - that is MFR in conjunction with joint mobilization and 3 dimensional myofascial release - that is fascia movements in three plane (sagittal, frontal and transverse) have received less attention. This two-arm randomized controlled trial will compare 3 dimensional and dynamic myofascial release in adults aged 20 to 40 years with CNSLBP. Participants will randomly allocated into two groups. Group A will receive 3 Dimensional myofascial release while group B will receive Dynamic myofascial release. Both groups also receive lumbar mobilization and exercise therapy program as the standard protocol for three sessions/week over four weeks. Outcomes will include pain intensity (NPRS), range of motion (Goniometer) and functional disability (ODI).

Study Overview

Status

Enrolling by invitation

Conditions

Intervention / Treatment

Detailed Description

Low back, lumbosacral, sacroiliac, and hip areas are the primary expression of low back pain (LBP), a set of pain disorders that commonly accompany leg discomfort, numbness, and weakness. The primary areas impacted are the lumbosacral joints, muscles, tendons, ligaments, fascia, and intervertebral discs. It is becoming a common condition in orthopedics and rehabilitation and a major public health concern. The likelihood of an ongoing disability course is increased by psychosocial distress, inadequate coping mechanisms, and a significant baseline disability. Ninety percent of cases of LBP are nonspecific, which means they do not have an obvious reason like an infection or tumor. Pain that spreads from the thoracic spine to the gluteal area and upper leg is a common sign. Pain that lasts 12 weeks or more is classified as chronic. Findings from a study that 79% of men and 89% of women with CLBP could not be diagnosed in a general practice setting led to the term ''nonspecific low back pain.'' Non-specific low back pain (NSLBP) is marked by limits in facet joints, increased myofascial thickness, and lower lumbar flexibility, which can lead to further dysfunction. People with either sudden or prolonged lower back pain need to be informed and supervised to sustain an active lifestyle. Pharmaceuticals (such as NSAIDs, Muscle Relaxant and Opioids) are indicated as second-line therapies for chronic LBP, following education, exercise (Pilates and Mckenze) and behavioral therapy. Long periods of standing or walking, heavy lifting, an unhealthy lifestyle, psychological variables and a history of LBP are all risk factors for nonspecific episodes. Physiotherapy provides a variety of back pain treatments including manual therapy, posture instruction and exercises. Movements that promote balanced activation and develop lumbar-supporting muscles include core stabilization exercises such as abdominal bracing, bridging and pelvic tilts. Tight hip flexors, lower back muscles and chest are the focus of stretching exercises. Manual therapy techniques such as myofascial release, joint mobilization and soft tissue massage relieve tension, remove limitations and enhance alignment. In everyday tasks, postural education emphasizes body mechanics and ergonomics concepts. Biomechanics, exercises, manual approaches and increased postural awareness are the cornerstones of holistic approach. Mobilization is a passive and slow rhythmic movement performed on symptomatic or hypomobile vertebrae. Posterior-anterior vertebral mobilization (PAVM), an important manual treatment technique, corrects misalignment, increases muscle strength, mobility, and flexibility, and aids in pain management via neural pathways. Manual passive stretching to increase muscular flexibility, strengthening exercises to boost core and spinal support, and lumbar stabilization activities to improve spinal stability and lower the likelihood of repeated discomfort are all potential components of a workout regimen for low back pain. The body's essential tissue network fascia is made up of both superficial and deep layers. Fascia, extensive layers of fibrous tissue, interconnects all body connective tissues, both contractile and non-contractile, supporting structural stability while allowing essential movement under normal conditions. Any restriction in the fascia can cause pain, stiffness, and limited ROM. The TLF is a multilayered aponeurotic structure with a diamond shape that divides the posterior abdominal wall muscles from the paraspinal muscles. The erector spinae muscles are covered by its posterior layer, which is controlled by the latissimus dorsi muscle insertion. Studies have highlighted TLF's nociceptive potential, which is caused by a sizable percentage of nociceptors and is consistent with innervation by both A and C fibers. Shearing action between TLF and erector spinae muscle's epimysium is reduced in LBP patient that are linked by decrease in TLF's elasticity, stiffening and sliding mobility which might lead to inflammation, proprioceptor dysfunction, micro-injuries and nociceptor sensitization. It is essential to understand the connection between back muscle function and TLF deformation during shoulder, scapula, thoracic spine, lumber spine, pelvic, and hip movements. Due to the abundance of free and capsulate nerve terminals, including Pacini's and Ruffini's corpuscles, TLF is one of the primary causes of the rise in non-specific LBP. The lumbopelvic fascia plays a significant role in NSLBP via mechanisms such as fibrosis and inflammation. Effective treatments may include resolving fascial dysfunctions, strengthening local stabilizers such as the transversus abdominis and multifidus, and controlling global mobilizers such as the erector spinae, in addition to pharmaceutical, alternative, and traditional therapy. Since the early days of osteopathy, myofascial release has been used as an osteopathic soft tissue stretching technique. It is defined as 'the facilitation of mechanical, neural and psychophysiological adaptive potential as interfaced via the myofascial system'. Persistent low back pain is mostly produced by myofascial discomfort . MFR techniques reduce pain, increase lumbar ROM, improve shortness of the lumbar myofascial tissue and posture, regain connective tissue elasticity and mechanical characteristics while minimizing muscle knots, boost flexibility along with fascial glide, speed up recovery, and ease symptoms in people with CNSLBP. The MFR Manual by Manheim lays out the fundamental ideas of 3 Dimensional Myofascial Release (3D-MFR) of John F. Barnes (PT) who was the first to widely educate that fascia is not a series of isolated linear bands and emphasizes the significance of seeing the fascia as a continuous, 3D network stretching from head to toe. Fascial limitations that span many planes of motion are the focus of 3D-MFR. It is especially helpful for myofascial pain syndrome, postural abnormalities, movement limitation after surgery, accident or immobilization, chronic neck and back pain. Its absolute contraindications are acute/active infection, fracture, cancer, deep vein thrombosis and open wounds. Relative contraindications that require precautions are osteoporosis, bleeding disorders, severe cardiopulmonary conditions and psychological distress. The therapist thoroughly assesses the patient to ensure technique's application safety and effectiveness. 3D-MFR improves traditional myofascial release. Unlike standard MFR, which focuses on elongation along a single line, 3D-MFR considers fascial restrictions in three planes: sagittal (vertical) fascia align with direction of gravity to stretch the tissue in response restriction release, frontal (horizontal) fascia align in front to back direction to restore tissue flexibility and alignment, and transverse (rotational) targets twisting or rotational movements of fascia. This multidimensional approach promotes pain relief, mobility, and overall function by addressing deeper tissue layers and correcting early soft tissue damage using the three-dimensional Release Technique (3-DRT), which includes passive muscle release approaches. Dynamic myofascial release (DMFR) is described by Dong-Woo Lee in 2019 research article. It is comparable to MFR for fascia release and joint movement for increase of ROM. In DMFR, patients are performing breathing in a synchronised pattern while the therapist is performing movement actively, whereas in MFR is passive approach by therapists in a static position. As a result, DMFR could be more successful in generating non-local systemic effects and increasing proprioception. DMFR manually applying a long duration, low amplitude stretch to the muscle and fascia between T6 and T12. The therapist smoothly moved the joints in a diagonal or horizontal direction at a leisurely pace within the ROM after instructing participants to relax as much as possible. At the end of ROM, the therapist shaken, pulled or pushed the joint region three to five times for three seconds. The patient continues to move during therapy. DMFR improves ROM and reduces pain. Musculoskeletal disorders, particularly CNSLBP, are prevalent conditions that can be treated by physical therapy. In a clinical setting, patients with low back pain are easily accessible. Changes in low back discomfort are linked to lumbar biomechanics, like increased fascial stiffness and limited motion. Restoring normal fascial gliding improves spinal mobility and reduces disability. This study has an objective to compare the effectiveness of dynamic myofascial release or three-dimensional myofascial release combined with lumbar mobilization and exercise therapy. After determining which intervention is more effective in reducing disability, improving range of motion, and relieving pain, physiotherapists can expect to benefit. Myofascial release therapies are gaining popularity for treating chronic non-specific low back pain, yet literature reveals significant gaps. Research primarily focuses on solitary treatments, with deficient exploration of myofascial release combined with lumbar mobilization and structured exercise. Furthermore, comparative studies on various myofascial techniques, including three-dimensional and dynamic release, are scarce, highlighting the need for well-structured randomized controlled trials in this area.

Study Type

Interventional

Enrollment (Estimated)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Punjab Province
      • Lahore, Punjab Province, Pakistan, 54000
        • Multazam Health Care

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 20 - 40 years
  • Both genders
  • LBP onset from > 12 weeks
  • Back pain localized between T12 and the gluteal fold
  • Pain provoked by movement or prolonged posture
  • SLR and slump tests: Negative; manual lumbar distraction: Positive
  • Pain intensity ≥ 3 on the Numerical Pain Rating Scale
  • Lumbar flexion < 65°, lumbar extension < 31°, lateral flexion < 30°, and rotation < 15.3°
  • The patient must have >40% ODI score.

Exclusion Criteria:

  • Cognitive impairment
  • Individuals with recent fractures or surgeries in the spine or lower limbs
  • Limb length discrepancy
  • Long-term medications like corticosteroids and painkillers affecting musculoskeletal symptoms
  • Ongoing physiotherapy or chiropractic treatment
  • Participants with lumbar or lower limb neurological defects
  • Patients with specific low back pain
  • Pregnant women
  • Systemic inflammatory disease
  • Those with severe cardiovascular conditions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 3 Dimensional Myofascial Release with lumbar mobilization and exercise therapy program

Participants with chronic non specific low back pain will receive 3 Dimensional Myofascial Release with lumbar mobilization and exercise therapy program.

Three sets of 90-second holds were used for 3DMFR. While the patient was seated for 3D-MFR, the therapist stood behind them. The 3D-MFR technique was performed from four separate positions. With one hand on the back of the shoulder and the other on the PSIS of the opposite side, the therapist started with a diagonal stretch. When one hand griped the posterior shoulder and the other griped the lateral aspect of the opposing shoulder, the trunk rotated. To keep a balanced fascial tension during these stretches, one hand gave force downward diagonally while the other extended upward and slightly forward. The end range was increased in each position by applying compression or additional stretch. The therapist gently twisted the patient's trunk while guided them into hyperextension and applied mild counter-pressure across the upper back to deepen the release. The therapist placed one hand on the patient's head and the other on their back to aid the extension movement

Other Names:
  • 3-D MFR

Standard physiotherapy treatment: Participants' positions should be in prone lying while the therapist stood on their side. The hypomobile spinous process of the lumbar vertebra was covered by the hand's ulnar surface. Another hand should be placed on the first one to generate force. With the therapist's shoulders precisely above the spinous process and elbows slightly bent, they executed rhythmic vertebral movements by giving the spinous process a central PA glide. Four applications of Grade III mobilization were made, each lasting 60 seconds of oscillation and 20 seconds of rest (two or three oscillations per second).

Other Names:
  • PA glide

Standard PT: The exercise therapy program began with a hot pack on the lumbar region for 15 minutes before treatment to prepare the soft tissue. TENS was applied for 15 minutes via 2 channels, four 5 x 5 cm electrodes placed paraspinally at T12-S1, at 60-120 Hz and a pulse width of 50-100 µs. Three times per session, the lower back extensors, hamstrings and iliopsoas were manually and passively stretched in prone, supine, and supine with knee to chest positions, respectively, holding each for 30 seconds. Strengthening comprised abdominal curls in supine and prone cobra pose for the back extensors, 10 reps, 2 sets. Lumbar stabilization included abdominal bracing in crook lying, side support (hips lifted, resting on one elbow and foot), and quadruped exercise with one leg raised and the hip extended to 30 degrees, each for 10 reps with an 8-second hold. Patient education covered staying active, avoiding prolonged bed rest, safe movements, correct lifting form, and gradual progression.

Active Comparator: Dynamic Myofascial Release with lumbar mobilization and exercise therapy program

Participants with chronic non specific low back pain will receive Dynamic Myofascial Release with lumbar mobilization and exercise therapy program.

Standard physiotherapy treatment: Participants' positions should be in prone lying while the therapist stood on their side. The hypomobile spinous process of the lumbar vertebra was covered by the hand's ulnar surface. Another hand should be placed on the first one to generate force. With the therapist's shoulders precisely above the spinous process and elbows slightly bent, they executed rhythmic vertebral movements by giving the spinous process a central PA glide. Four applications of Grade III mobilization were made, each lasting 60 seconds of oscillation and 20 seconds of rest (two or three oscillations per second).

Other Names:
  • PA glide

Standard PT: The exercise therapy program began with a hot pack on the lumbar region for 15 minutes before treatment to prepare the soft tissue. TENS was applied for 15 minutes via 2 channels, four 5 x 5 cm electrodes placed paraspinally at T12-S1, at 60-120 Hz and a pulse width of 50-100 µs. Three times per session, the lower back extensors, hamstrings and iliopsoas were manually and passively stretched in prone, supine, and supine with knee to chest positions, respectively, holding each for 30 seconds. Strengthening comprised abdominal curls in supine and prone cobra pose for the back extensors, 10 reps, 2 sets. Lumbar stabilization included abdominal bracing in crook lying, side support (hips lifted, resting on one elbow and foot), and quadruped exercise with one leg raised and the hip extended to 30 degrees, each for 10 reps with an 8-second hold. Patient education covered staying active, avoiding prolonged bed rest, safe movements, correct lifting form, and gradual progression.

DMFR was given for 15 minutes per session as a manual, low-amplitude, long-duration stretch targeting fascia and muscles. Participants remained relaxed while the therapist performed slow diagonal or horizontal joint motions within available ROM, using gentle pushing, pulling or shaking for 3-5 repetitions of about 3 s, ending with some mobilization. Step 1: the therapist supported one arm and pulled the shoulder with breathing. Step 2: the participant's elbows rested on the therapist's lap, hands behind neck, synchronized with breathing. Step 3: the upper flexed knee was supported while pelvis and lower limb were led through gait-cycle motions. Step 4: the iliac crest was moved in all four directions. Finally, in prone, shoulder and pelvic girdles were gently counter-rotated.

Other Names:
  • DMFR

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity on Numeric Pain Rating Scale (NPRS)
Time Frame: Baseline (pre) and at the 4th Week of Study (post)

Pain intensity will be measured using a numeric rating scale (NRS). Participants will rate their current pain severity using an 11-point pain numerical rating scale ranging from 0 (no pain at all) to 10 (the worst imagined pain). It interpret as 0: No Pain, 1-3: Mild Pain, 4-6: Moderate Pain and 7-10: Severe Pain.

Baseline (pre) and at the 4th Week of Study (post)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lumbar Range of Motions by Goniometer
Time Frame: Baseline (pre) and at the 4th Week of Study (post)

Lumbar ROM will be assessed using a manual goniometer according to standard clinical protocols. Common movements include lumbar flexion (forward bending), extension (backward bending), lateral flexion (side bending), and rotation. The participant should remain in a neutral position for 5 s, then the ROM assessment will be conducted: lumbar flexion, lumbar extension, lumbar lateral flexion, and lumbar rotation. Scientific evidence of normal lumbar flexion (65°), lumbar extension (31°), lateral flexion (30°), and rotation (15.3°).

Baseline (pre) and at the 4th Week of Study (post)
Functional Disability in Oswestry Disability Index (ODI)
Time Frame: Baseline (pre) and at the 4th Week of Study (post)

Functional impairment will be measured using the Oswestry Disability Index (ODI). Participants will mark replies in ten categories on a 0-5 scale using the original English ODI version. Scores will be computed as (counted marks/50 × 100%). Mild disability is classified as 0-20%, moderate disability as 21-40%, severe disability as 41-60%, crippled handicap as 61-80%, and total disability as 81-100%.

Baseline (pre) and at the 4th Week of Study (post)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Syed Shakil Ur Rehman, PhD, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2026

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

November 10, 2026

Study Registration Dates

First Submitted

November 2, 2026

First Submitted That Met QC Criteria

November 2, 2026

First Posted (Actual)

November 6, 2026

Study Record Updates

Last Update Posted (Actual)

November 6, 2026

Last Update Submitted That Met QC Criteria

November 2, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • REC/RCR & AHS/25/0154

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.